Rewards

Novo-Nordisk A/S (NVO)

Underlying price

$40.35

+0.12% today

Stock stats

Market cap
$177B
Previous close
$40.30
Open
$39.76
Day's range
$39.58 – $40.54
52-week range
$35.12 – $64.16
Volume
8.48M
Avg volume
12.2M
P/E ratio
10.18
EPS
$3.96
Dividend yield
4.45%
Beta
0.699
Next earnings
-

About Novo-Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Ticker
NVO
Asset class
Equity
Tokenized by
2 issuers
Employees
69,500

Novo-Nordisk A/S FAQ

NVO is Novo-Nordisk A/S stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Novo-Nordisk A/S trades here as 2 tokens rather than one.